165 related articles for article (PubMed ID: 3762738)
1. Relation between brain monoamine oxidase (MAO) activity and the firing rate of locus coeruleus neurons.
Oreland L; Engberg G
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul; 333(3):235-9. PubMed ID: 3762738
[TBL] [Abstract][Full Text] [Related]
2. A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain.
Fagervall I; Ross SB
J Neurochem; 1986 Aug; 47(2):569-76. PubMed ID: 3734795
[TBL] [Abstract][Full Text] [Related]
3. Noradrenaline-degrading activity of monoamine oxidase is localized in noradrenergic neurons of the locus coeruleus of the rat.
Hasegawa Y; Hida T; Arai R
Neurosci Lett; 1999 Apr; 264(1-3):61-4. PubMed ID: 10320014
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of locus coeruleus neuronal activity by beta-phenylethylamine.
Lundberg PA; Oreland L; Engberg G
Life Sci; 1985 May; 36(19):1889-96. PubMed ID: 3990515
[TBL] [Abstract][Full Text] [Related]
5. In vivo degradation of noradrenaline by MAO A in locus coeruleus of the rat.
Blinc M; Dernovsek M; Sket D
Experientia; 1989 Dec; 45(11-12):1099-102. PubMed ID: 2513220
[TBL] [Abstract][Full Text] [Related]
6. Preferential localization of monoamine oxidase type A activity in neurons of the locus coeruleus and type B activity in neurons of the dorsal raphe nucleus of the rat: a detailed enzyme histochemical study.
Arai R; Kimura H; Nagatsu I; Maeda T
Brain Res; 1997 Jan; 745(1-2):352-6. PubMed ID: 9037433
[TBL] [Abstract][Full Text] [Related]
7. The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation.
Braestrup C; Andersen H; Randrup A
Eur J Pharmacol; 1975 Nov; 34(1):181-7. PubMed ID: 1241962
[TBL] [Abstract][Full Text] [Related]
8. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
Lamensdorf I; Youdim MB; Finberg JP
J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
[TBL] [Abstract][Full Text] [Related]
10. The effect of deprenyl (selegiline) on intra- and extraneuronal dopamine oxidation.
Oreland L; Arai Y; Stenström A
Acta Neurol Scand Suppl; 1983; 95():81-5. PubMed ID: 6428149
[TBL] [Abstract][Full Text] [Related]
11. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
Severina IS
Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
[TBL] [Abstract][Full Text] [Related]
12. Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons.
Engberg G; Elebring T; Nissbrandt H
J Pharmacol Exp Ther; 1991 Nov; 259(2):841-7. PubMed ID: 1658311
[TBL] [Abstract][Full Text] [Related]
13. Distribution of the two forms of monoamine oxidase within monoaminergic neurons of the guinea pig brain.
Ross SB
J Neurochem; 1987 Feb; 48(2):609-14. PubMed ID: 3098921
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of monoamine oxidase by p-aminosubstituted phenylalkylamines in catecholaminergic neurones.
Ask AL; Fagervall I; Florvall L; Ross SB; Ytterborn S
Neuropharmacology; 1986 Jan; 25(1):33-40. PubMed ID: 3005903
[TBL] [Abstract][Full Text] [Related]
15. Alteration of dopamine synthesis in rat striatum subsequent to selective type A monoamine oxidase inhibition.
Schoepp DD; Azzaro AJ
J Neurochem; 1981 Aug; 37(2):527-30. PubMed ID: 6790675
[TBL] [Abstract][Full Text] [Related]
16. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
Karoum F
Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
[TBL] [Abstract][Full Text] [Related]
17. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
Cabanillas AM; Masini-Repiso AM; Costamagna ME; Pellizas C; Coleoni AH
J Endocrinol; 1994 Nov; 143(2):303-8. PubMed ID: 7829993
[TBL] [Abstract][Full Text] [Related]
18. In vivo, noradrenaline is a substrate for rat brain monoamine oxidase A and B.
Youdim MB
Br J Pharmacol; 1983 Jun; 79(2):477-80. PubMed ID: 6652339
[TBL] [Abstract][Full Text] [Related]
19. Monoamine oxidase activity in noradrenaline neurons of the locus coeruleus of the rat. A double-labeling histochemical study.
Hida T; Arai R
Brain Res; 1998 Dec; 814(1-2):209-12. PubMed ID: 9838121
[TBL] [Abstract][Full Text] [Related]
20. Different alpha(2) adrenoceptor subtypes control noradrenaline release and cell firing in the locus coeruleus of wildtype and monoamine oxidase-A knockout mice.
Owesson CA; Seif I; McLaughlin DP; Stamford JA
Eur J Neurosci; 2003 Jul; 18(1):34-42. PubMed ID: 12859335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
